Detalles de la búsqueda
1.
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.
Lancet Oncol
; 21(4): 541-550, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32192573
2.
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study.
Cancer
; 126(24): 5303-5310, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914879
3.
Vaginal Diazepam for Nonrelaxing Pelvic Floor Dysfunction: The Pharmacokinetic Profile.
J Sex Med
; 16(6): 763-766, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010782
4.
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315).
Cancer
; 124(23): 4548-4555, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30394521
5.
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 65(8): e27077, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29693796
6.
A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).
Pediatr Blood Cancer
; 64(11)2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28449393
7.
A Phase I trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies.
Clin Cancer Res
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38530846
8.
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future.
Chem Soc Rev
; 41(7): 2943-70, 2012 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22388295
9.
Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer.
NPJ Breast Cancer
; 9(1): 101, 2023 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114522
10.
Mouse pharmacokinetics and metabolism of the phenylurea thiocarbamate NSC 161128.
Cancer Chemother Pharmacol
; 90(2): 161-174, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35896839
11.
Vascular Endothelial Growth Factor as an Immediate-Early Activator of Ultraviolet-Induced Skin Injury.
Mayo Clin Proc
; 97(1): 154-164, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34823856
12.
Inorganic nanoparticles in cancer therapy.
Pharm Res
; 28(2): 237-59, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21104301
13.
Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates.
J Ocul Pharmacol Ther
; 37(5): 251-260, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33784195
14.
Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP/PS1 female mice.
Commun Biol
; 4(1): 61, 2021 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33420340
15.
Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits.
PLoS One
; 15(4): e0231841, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32298376
16.
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312).
Clin Cancer Res
; 26(6): 1213-1219, 2020 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31857431
17.
Author Correction: Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP/PS1 female mice.
Commun Biol
; 7(1): 234, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38409374
18.
Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.
Clin Cancer Res
; 24(24): 6142-6149, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30093449
19.
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial.
J Clin Oncol
; 34(12): 1368-75, 2016 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26884555
20.
Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth.
ACS Nano
; 10(12): 10636-10651, 2016 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27758098